The Profiles of Hepatitis B and C Virus Infections in Prison-Assisted Citizens


Prison-assisted citizens or prisoners are one of the groups of people who are at high risk of Hepatitis B and C virus infections. The data on the prevalence of both viruses in prisoners in Indonesia are still limited. This study aims to determine the profiles of Hepatitis B and C virus infections in prison-assisted citizens in the Class IIA Narcotics Correctional Institution in Bandung Regency. A total of 30 prisoners were used as the samples in this study. All procedures performed in this study were following the applicable codes of ethics. The presence of surface antigens of Hepatitis B virus (HBsAg) in serums was detected using a qualitative sandwich Enzyme-Linked Immunosorbent Assay method. The existence of antibodies of the Hepatitis C virus (Anti-VHC) was detected using the immunochromatography method. The laboratory test results have shown five people (16.7%) were positive on the HBsAg test and one person (3.3%) was positive on the anti-VHC test. One case of Hepatitis B and C co-infection was also found in the prison-assisted citizens who were in the Class IIA Narcotics Correctional Institution in Bandung Regency. All the prisoners infected by the Hepatitis B and C viruses used injection drugs, had tattoos on their bodies and never received vaccinations.


Andriansyah, I. (2018). Dampak Penempatan Kamar Hunian Melebihi Daya Tampung yang Menyebabkan Perkelahian antar Narapidana di Lembaga Pemasyarakatan Kelas II A Narkotika Bandung (Skripsi). Universitas Pasundan, Bandung.
Behzadifar, M., Gorji, H.A., Rezapour, A. & Bragazzi, N.L. (2018). Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis. Harm Reduct J 15, 24.
Gahrton, C., Westman, G., Lindahl, K., Öhrn, F., Dalgard, O., Lidman, C., Nilsson, L.-H., Said, K., Duberg, A.-S., & Aleman, S. (2019). Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County. BMC Infect Dis 19, 955.
Ghafari, S., Sharifzadeh, G., Jamali, S., Taji, B., Javadmoosavi, S.Y., & Ziaee, M., (2019). Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran. Arch Iran Med 22, 4.
Gupta, E., Bajpai, M., Choudhary, A. (2014.) Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays. Asian journal of transfusion science 8, 19–25.
Keten, D., Emin Ova, M., Sirri Keten, H., Keten, A., Gulderen, E., Tumer, S., Caliskan, A., & Kulotu, S. (2016). The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey. Jundishapur J Microbiol 9.
Kivimets, K., Uusküla, A., Lazarus, J.V. & Ott, K. (2018). Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015. BMC Infect Dis 18, 339.
Kudesia, G. & Wreghitt, T. (2009). Clinical and Diagnostic Virology. Cambridge University Press, Cambridge.
Moradi, G., Goodarzi, E., & Khazaei, Z. (2018). Prevalence of Hepatitis B and C in prisons worldwide: A meta-analysis during the years 2005-2015. Biomed. Res. Ther. 5, 2235–2251.
Naully, P.G. & Romlah, S., (2019). Deteksi Gen sHBsAg sebagai Penanda Koinfeksi Hepatitis B pada Pengidap HIV. Jurnal Kesehatan 10, 236–244.
Nelwan, E.J., Van Crevel, R., Alisjahbana, B., Indrati, A.K., Dwiyana, R.F., Nuralam, N., Pohan, H.T., Jaya, I., Meheus, A., & van Der Ven, A. (2010). Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening: Blood-borne infections in an Indonesian prison. Tropical Medicine & International Health 15, 1491–1498.
Prasetyo, A.A., Dirgahayu, P., Sari, Y., Hudiyono, H., & Kageyama, S. (2013). Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia. J Infect Dev Ctries 7, 453–467.
Ramin, A., Fatemeh, A., Seyed-Mostafa, H.-Z., Farideh, A.D., Mohammad Parsa, M., & Mahmoud, N. (2015.) Prevalence of Hepatitis B and C in Male Prisoners in Iranian Prisons in 2012. ijtmgh 3, 199–202.
Rey, I., Saragih, R.H., Effendi-YS, R., Sembiring, J., Siregar, G.A. & Zain, L.H. (2018). Profile of hepatitis B and C virus infection in prisoners in Lubuk Pakam correctional facilities. IOP Conf. Ser.: Earth Environ. Sci. 125, 012033.
Smith, J.M., Uvin, A.Z., Macmadu, A. & Rich, J.D. (2017). Epidemiology and Treatment of Hepatitis B in Prisoners. Curr Hepatology Rep 16, 178–183.
Viswanathan, U., Beaumont, A., O’Moore, E., Ramsay, M., Tedder, R., Ijaz, S., Balogun, K., & Kirwan, P. (2011). Hepatitis B transmission event in an English prison and the importance of immunization. Journal of Public Health 33, 193–196.
WHO, 2017. Global Hepatitis Report. WHO, Geneva.
  • Patricia Gita Naully Department of Medical Laboratory Technology (D-4), Stikes Jenderal Achmad Yani Cimahi. West Java, Indonesia
Keywords: hepatitis B, hepatitis C, prison-assisted citizens
How to Cite
Naully, P. (2020). The Profiles of Hepatitis B and C Virus Infections in Prison-Assisted Citizens. Biomedika, 13(1), 51-57.
Abstract viewed = 0 times
PDF (English) downloaded = 0 times